Company Filing History:
Years Active: 2015
Title: Dharmalingam Subramanlam: Innovator in Cancer Detection and Treatment
Introduction
Dharmalingam Subramanlam is a notable inventor based in Overland Park, Kansas. He has made significant contributions to the field of cancer research, particularly in the detection and treatment of cancer stem cells. His innovative work has the potential to impact cancer therapies and improve patient outcomes.
Latest Patents
Dharmalingam holds 1 patent for his invention titled "Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereof." This patent focuses on DCAMKL-1, which has been identified as a biomarker for stem cells and cancer stem cells. The methods disclosed in his patent include detecting the presence of stem cells, isolating stem cells, and inhibiting the growth of cancer cells utilizing DCAMKL-1.
Career Highlights
Dharmalingam Subramanlam is affiliated with the University of Oklahoma, where he continues to advance his research in cancer detection and treatment. His work is crucial in the ongoing battle against cancer, providing new avenues for diagnosis and therapy.
Collaborations
Some of his notable coworkers include Shrikant Anant and Courtney W. Houchen. Their collaborative efforts contribute to the innovative research environment at the University of Oklahoma.
Conclusion
Dharmalingam Subramanlam's contributions to cancer research through his innovative patent highlight the importance of ongoing research in the medical field. His work exemplifies the potential of scientific innovation to transform cancer detection and treatment.